TPD Archives - Medicilon

Medicilon TPD (PROTAC, Molecular Glue) Service Platform

Targeted protein degradation (TPD) is a promising therapeutic strategy that harnesses the intracellular proteasome or lysosome system to eliminate disease-causing proteins. TPD offers several advantages over traditional therapies, including the ability to target previously “undruggable” proteins, overcome drug resistance, and achieve high selectivity. Key TPD modalities like PROTACs and molecular glues have seen advancements in […]